Ott et al. found that dexamethasone can decrease the level of tryptophan-2, 3-dioxygenase (TDO), one of rate-limiting enzymes of tryptophan metabolism in human gliomas [34]. This evidence concerns the gene TDO2 and central nervous system cancer.